Csenge Advisory Group Makes New $2.62 Million Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Csenge Advisory Group purchased 6,297 UnitedHealth shares during the second quarter, valued at approximately $2.62 million. Institutional investors collectively own 87.86% of the company.
• UnitedHealth reported quarterly EPS of $6.38, exceeding the $4.94 consensus estimate, while revenue reached $112.03 billion. The company maintained fiscal 2026 EPS guidance of $19.50–$20.00.
• Analysts remain broadly optimistic, with a consensus “Moderate Buy” rating and a $455.92 target price, though rising health-care costs and slower Medicare Advantage enrollment growth could pressure margins.

Csenge Advisory Group purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 6,297 shares of the healthcare conglomerate's stock, valued at approximately $2,617,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $25,000. Anfield Capital Management LLC increased its holdings in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $27,000. Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $27,000. Finally, Lifetime Wealth Management P.C. bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $29,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is reportedly prioritizing Medicare Advantage profitability over rapid membership growth by tightening benefits, improving pricing and controlling costs. The strategy could support stronger margins and more sustainable earnings, even if enrollment growth moderates. Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?
• Positive Sentiment: Zacks Research added UNH to its Rank #1, or “Strong Buy,” lists for overall stocks, value stocks and income stocks. The repeated favorable rankings may reinforce investor confidence in the shares. New Strong Buy Stocks for August 21st
• Positive Sentiment: Analysts raised several forward EPS estimates, including Q1 2028 to $7.36 from $6.78 and Q2 2028 to $7.19 from $5.84. A separate report also noted an increase in the Q1 EPS estimate, while Zacks maintained a Strong Buy rating. Q1 EPS Estimate for UnitedHealth Group Increased by Analyst
• Neutral Sentiment: Forecast revisions were mixed: Q3 2027 EPS was reduced to $4.74 from $4.81 and Q4 2027 to $4.07 from $4.12, partially offsetting the increases for 2028.
• Negative Sentiment: Aon expects U.S. employer health-care costs to rise 9.5% in 2027. Persistent medical-cost inflation could pressure insurers’ margins and increase pricing, benefit and utilization-management challenges for UnitedHealth. AON Sees No Relief From Health-Cost Inflation

UnitedHealth Group Price Performance

NYSE UNH opened at $390.94 on Friday. The stock has a market capitalization of $350.90 billion, a PE ratio of 25.16, a P/E/G ratio of 1.36 and a beta of 0.62. The stock has a 50-day simple moving average of $413.99 and a 200 day simple moving average of $355.96. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the previous year, the business posted $4.08 EPS. The company's revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 19.81 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio is presently 59.72%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. UBS Group upped their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a "buy" rating in a report on Friday, July 17th. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $466.00 to $516.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 21st. Erste Group Bank raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday, April 27th. Royal Bank Of Canada increased their price target on UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a report on Friday, July 17th. Finally, KeyCorp boosted their price objective on shares of UnitedHealth Group from $400.00 to $475.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $455.92.

Insider Transactions at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 500 shares of the business's stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total transaction of $205,000.00. Following the transaction, the chief executive officer owned 16,497 shares in the company, valued at approximately $6,763,770. The trade was a 2.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.19% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source